UMBC biotech startup raises $1.5 million
Plasmonix Inc., a biotech startup whose technology comes from research at the University of Maryland, Baltimore County, this week announced it raised $1.5 million of a planned $2 million Series A equity offering.
The investment was led by the Maryland Healthcare Product Development Corp. Plasmonix is working on commercializing a technology called Metal Enhanced Fluorescence, which was developed at UMBC.
Basically, the technology enables super-fast detection of heart attacks, sexually transmitted diseases, salmonella -- within 20 seconds.
Watch the Youtube video of founder and MEF inventor Dr. Chris Geddes (Other founders include William M. Gust II, President and CEO and Dr. John Holaday, Chairman.)
Categories: *NEWS*, BioTech, East Coast, Entrepreneurs & Risk Takers







